about
Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.Formation of acetyl-Ser-Asp-Lys-Pro, a new regulator of the hematopoietic system, through enzymatic processing of thymosin beta 4.Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic AgentTumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxiaDifferential effects of Bartonella henselae on human and feline macro- and micro-vascular endothelial cellsInvolvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system.Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.News on microenvironmental physioxia to revisit skin cell targeting approaches.Trojan horse at cellular level for tumor gene therapies.MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.Improvement of polyphenol properties upon glucosylation in a UV-induced skin cell ageing model.CD133 positive progenitor endothelial cell lines from human cord blood.Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment.Pharmacokinetics of 1-nitrosomelatonin and detection by EPR using iron dithiocarbamate complex in mice.Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia.Serotonin binds to purified neuronal nitric oxide synthase: a possible explanation for ROS production induced by 5HT in the presence of nNOS.A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection.The endogenous neurotransmitter, serotonin, modifies neuronal nitric oxide synthase activities.Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAsDeveloping a circularly permuted variant of Renilla luciferase as a bioluminescent sensor for measuring Caspase-9 activity in the cell-free and cell-based systemsEndothelium in Pathologic Angiogenesis and Angiogenesis-Mediated TherapiesSynthesis and biological evaluation of analogues of the tetrapeptideN-acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferationOptimization of Cell Culture Conditions for the Evaluation of the Biological Activities of the Tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro, a Natural Hernoregulatory FactorThe tetrapeptide acserasplyspro (seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3′‐Azido‐3′‐deoxythymidine to human hematopoietic progenitorsChanges in the expression of lectins in human T lymphocyte membrane upon mitogenic stimulationSoluble human lymphocyte sugar binding proteins with immunosuppressive activityCell surface lectins of human granulocytes: their expression is modulated by mononuclear cells and granulocyte/macrophage colony-stimulating factorThe Immunomodulatory Effect of IrSPI, a Tick Salivary Gland Serine Protease Inhibitor Involved in Ixodes ricinus Tick Feeding
P50
Q30540976-6E950CF8-31C7-4A26-8D9C-60D30674CCDAQ33652254-F8FA39F6-2B5B-4688-91FA-1E4ABDE01FEAQ33744134-83CF5610-A203-4234-8FDD-2BE116476F94Q33761936-F4494938-1BAB-428F-BCCD-29B9CDF0B0AEQ33798508-093CBB63-3079-48BB-B5FA-3CF6FD6B158BQ33920983-F1CF7FE2-A139-4ADC-9A2F-8620FC77E741Q34248639-8B0631E4-1F4C-4D5C-8305-EE0BAF405149Q36284267-790D96A7-EA59-413F-83AF-3B7E9B5057B9Q37483716-CEEEA504-27C9-4089-BBBA-AFAD297B8515Q37996791-5949A3B8-5E06-4599-976B-33C947F38A18Q38033656-E1069FDE-B2EA-48B9-9FEF-7E643DD7B003Q38094476-83136381-99A3-4A0A-9368-34949E12F22CQ38098095-65BF4B26-537F-4C80-9C1A-C11FED2710ABQ38958915-5C27CF38-4FE1-406C-A4DD-74DE1BE52EBBQ39516716-307DAE52-0597-4821-93C7-CEEB921C4ED6Q39660255-36E022E1-E171-433B-ABE1-C10A136C4254Q42816144-324CBA35-25C8-43D3-BF21-BE4C73729FEEQ45880773-D57663F3-1F4B-43AE-8D49-47D9861BAA74Q46134717-8CC8189E-0C76-4D54-AF7B-4D2A8552FFBBQ47950626-30ECC443-FCA4-4667-9CD0-56B4E453C77EQ48191086-3CFDB53A-A0E5-423C-8374-385D6D44235FQ57280000-5B768489-50A9-4AF9-9B81-5D98719B6849Q58609377-497324B2-25B0-4C14-AF2D-5EFD79F2517DQ59661697-F10F1506-BC01-4A13-B700-3D906FF92EE5Q59661714-6DD376C3-364E-4BC8-9DE7-BB6AA15B22E0Q59661717-74837268-3663-42D5-B79F-DFB9C6249C95Q59661719-1013139D-3D18-4B6B-9038-9B54EC9314FCQ59661720-A7693F4C-093D-4200-90B6-F8069869CB49Q59661724-F5487F36-A9B1-4DBB-B1F9-15ED34013BBEQ59661725-5BA10967-D907-4B75-ACF1-875AEEC69FD7Q90723003-4BE7F3A2-1123-41E4-AD21-4188A094538B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catherine Grillon
@ast
Catherine Grillon
@en
Catherine Grillon
@es
Catherine Grillon
@fr
Catherine Grillon
@nl
Catherine Grillon
@sl
type
label
Catherine Grillon
@ast
Catherine Grillon
@en
Catherine Grillon
@es
Catherine Grillon
@fr
Catherine Grillon
@nl
Catherine Grillon
@sl
prefLabel
Catherine Grillon
@ast
Catherine Grillon
@en
Catherine Grillon
@es
Catherine Grillon
@fr
Catherine Grillon
@nl
Catherine Grillon
@sl
P1053
I-4974-2016
P106
P1153
8374167900
P21
P31
P3829
P496
0000-0001-5019-7831